Characteristic | CVD only (n = 718) | CVD and CKD (n = 388) | CVD and diabetes (n = 81) | CVD and diabetes and CKD (n = 69) |
---|---|---|---|---|
Mean age in years | 68.6 | 74.9 | 68.8 | 74.8 |
Female, % | 24.5 | 54.1 | 25.6 | 50.7 |
Current smoker, % | 32.4 | 26.6 | 28.4 | 19.0 |
Previous CVD event, % | ||||
Myocardial infarction | 48 | 43.7 | 46.9 | 39.7 |
Angina | 84.6 | 87.6 | 86.4 | 85.3 |
Heart failure | 5.3 | 8.1 | 3.7 | 14.5 |
Previous CVD intervention, % | ||||
Coronary artery bypass graft | 19.1 | 17.8 | 22 | 24.6 |
Percutaneous coronary intervention | 16.1 | 10.5 | 12.2 | 10.3 |
Previous comorbidity, % | ||||
Peripheral vascular disease | 3.9 | 5.3 | 14.6 | 15.9 |
Stroke | 3 | 5.6 | 9.8 | 8.7 |
Thromboembolism: PE, DVT, TIA | 9.3 | 14.7 | 7.3 | 14.5 |
Baseline clinical status, mean (SD) | ||||
Systolic blood pressure, mmHg | 137.5 (18.1) | 139.8 (20.2) | 142.3 (18.6) | 143.9 (22.0) |
Diastolic blood pressure, mmHg | 80.9 (9.8) | 80.3 (8.6) | 82.9 (8.1) | 80.6 (8.6) |
Total cholesterol, mmol/L | 5.3 (1.0) | 5.5 (1.1) | 5.1 (1.2) | 5.3 (1.1) |
Baseline medication, % | ||||
Aspirin | 75.7 | 71.9 | 81.7 | 72.5 |
Beta-blocker | 48.9 | 46.8 | 35.4 | 39.1 |
Lipid-lowering agent | 51.3 | 44.5 | 53.7 | 50.7 |
ACE inhibitor | 23.6 | 24.3 | 43.9 | 43.5 |
↵a Total number of patients = 1256. ACE = angiotensin-converting enzyme. CKD = chronic kidney disease. CVD = cardiovascular disease. DVT = deep vein thrombosis. PE = pulmonary embolism. TIA = transient ischemic attack.